503Pharma

Efficient Compliance Training

Quick Poll: What’s the #1 Task You’d Love to Automate For Your Pharmacy?

Help us pick from 7 AI-powered tools — and get early access to the winner!

Weekly Compounding Pharmacy Reads

Eli Lilly Sues Compounding Pharmacies Over Tirzepatide Products. Hims & Hers Health Adds Eli Lilly's Zepbound to Telehealth Platform. Regulatory Status of Peptide Compounding in 2025. Featured Compound Formula. Understanding Gross Margins in Compounding: What’s a Healthy Profit Margin?

Weekly Compounding Pharmacy Reads

Lilly selling new higher-dose vials of Zepbound at lower price. Drug Compounders sue FDA over removal of Wegovy, Ozempic from shortage list. Global compounding pharmacy market projected to grow significantly. Featured Compounding Formula. Financial Pitfalls to Avoid When Running a Compounding Pharmacy

Weekly Compounding Pharmacy Reads

Wegovy & Ozempic removed from shortage list. Lilly, Novo fight weight-loss drug compounders, but they fight back. Featured compounding formula. Important business metrics for your pharmacy.

Weekly Compounding Pharmacy Reads

FDA Will Maintain Enforcement Discretion for Compounding Tirzepatide Injections. Heightened Oversight of Compounders. Novo Nordisk Loses in Court. Featured Compound Formula

Weekly Compounding Pharmacy Reads

FDA Approves Ketamine Nasal Spray, Trump Reverses Biden Policies on Drug Pricing, Featured Compound Formula

Weekly Compounding Pharmacy Reads

Retatrutide produces greatest weight loss, Lilly to join GLP-1 lawsuit, Featured compound formulation, Best practices for sterile compounding

Weekly Compounding Pharmacy Reads

FDA drug approvals, Medicare Part D changes, Featured compound formulation, AI in inventory management

Weekly Compounding Pharmacy Reads

Your source of relevant information about the practice and business of compounding pharmacies